In addition, through pan-cancer analysis, we further demonstrated that SLCO1B1 has a high immune infiltration status in most tumors, especially in B cells, dendritic cells, CD8+ T cells, macrophages, Tregs, and T-cell follicular helper cells. Here, SLCO1B1 is linked to cancer.